SCHA and VB Offer Similar Small-Cap ETF Advantages, but Which Is the Better Buy?

Vanguard Small-Cap ETF (VB) and Schwab U.S. Small‑Cap ETF (SCHA) are low‑cost, passive small‑cap index funds with nearly identical expense ratios (VB 0.03% vs SCHA 0.04%) and broad diversification (VB ~1,324 holdings; SCHA ~1,730 holdings). As of Feb. 9, 2026 SCHA outperformed over one year (16.27% vs 12.49%), but VB has delivered marginally stronger five‑year growth ($1,292 vs $1,221), far larger AUM ($169B vs $20B) and slightly higher dividend yield (1.27% vs 1.19%). SCHA tilts more toward technology and shows higher beta and a deeper five‑year max drawdown (-30.79% vs -28.16%), while VB leans industrials and offers greater liquidity, so choice should hinge on investors’ preference for tech exposure and willingness to accept volatility versus cost/liquidity considerations.

Analysis

Market structure: VB ($169B AUM, 0.03% ER) benefits from scale/liquidity and likely wins larger institutional allocations and rebalancing flows, while SCHA ($20B, 0.04% ER) benefits from momentum-seeking tech exposure (beta 1.29 vs 1.23) that produced 16.3% 1‑yr return vs VB's 12.5%. Winners: industrial cyclicals (VB-heavy) if growth surprises; tech small-caps (SCHA-heavy) on risk-on momentum. Losers: thinly traded micro-caps excluded from these indexes who face lower natural liquidity and wider spreads.

Risk assessment: Key tail risks are a Fed-rate re‑acceleration (2yr yield spike >+50bp in 30 days) that would compress small‑cap multiples and trigger >10% ETF outflows, and a liquidity-driven tracking error for SCHA given smaller AUM. Near-term (days–weeks): quarter‑end flows, CPI/jobs prints; short-term (3–6 months): earnings/AI headlines; long-term (12–36 months): Fed pivot and IPO/rescue dynamics. Hidden dependency: index methodology (Dow Jones vs CRSP) drives sector drift and reconstitution flow asymmetries.

Trade implications: Implement a relative-value pair: long VB / short SCHA sized 1–2% net exposure to capture liquidity/volatility premium over 6–12 months (stop 6%, target 200–400bp relative). For directional exposure, buy SCHA 3‑month puts 3–4% OTM as cheap tail-hedge if allocating >2% to small-cap tech; alternatively sell VB covered calls to harvest yield if neutral (30–60 day, 8–12% OTM). Individually, accumulate LITE and CIEN on pullbacks >10% with 12–24 month horizon given their index weights and secular tech demand.

Contrarian angles: Consensus underestimates the chance that SCHA’s recent outperformance is mean-reverting once momentum fades; liquidity premium can flip quickly—histor parallel: 2018 small‑cap tech correction after rate volatility. Reaction is likely underdone: retail chasing SCHA could steepen implied-volatility skews, creating opportunities to buy put spreads on SCHA vs VB. Unintended consequence: chasing SCHA for 1‑yr returns risks outsized drawdowns (~>30%) if macro tightens.

Key Decisions for Investors

• Establish a pair trade: +1.5% long Vanguard Small‑Cap ETF (VB) and −1.5% short Schwab U.S. Small‑Cap ETF (SCHA), 6–12 month horizon; set stop‑loss at 6% absolute on either leg and take-profit if relative outperformance reaches 200–400 bps.
• If holding or adding SCHA exposure >2% of portfolio, buy 3‑month SCHA puts 3–4% OTM sized to cover that notional (cost as hedge against a 10–30% small‑cap shock ahead of next CPI/jobs prints).
• Accumulate Lumentum (LITE) up to 1.5% position and Ciena (CIEN) up to 1.0% on pullbacks of ≥10% from current levels; target 12–24 month hold, trim into strength at +30–40% price moves.
• Sell 30–60 day covered calls on VB at 8–12% OTM to harvest yield (expect 1–3% annualized alpha) if neutral; avoid adding to pure small‑cap tech exposure unless 2‑yr Treasury yield falls below 4.50% within a 90‑day window, which would signal a tactical pivot to long SCHA.